Endometriosis
Open accessThe DOI matches its Crossref record; 208 of the 214 references it cites were found in a registry or an index.
Abstract
Pelvic endometriosis is a complex syndrome characterized by an estrogen-dependent chronic inflammatory process that affects primarily pelvic tissues, including the ovaries. It is caused when shed endometrial tissue travels retrograde into the lower abdominal cavity. Endometriosis is the most common cause of chronic pelvic pain in women and is associated with infertility. The underlying pathologic mechanisms in the intracavitary endometrium and extrauterine endometriotic tissue involve defectively programmed endometrial mesenchymal progenitor/stem cells. Although endometriotic stromal cells, which compose the bulk of endometriotic lesions, do not carry somatic mutations, they demonstrate specific epigenetic abnormalities that alter expression of key transcription factors. For example, GATA-binding factor-6 overexpression transforms an endometrial stromal cell to an endometriotic phenotype, and steroidogenic factor-1 overexpression causes excessive production of estrogen, which drives inflammation via pathologically high levels of estrogen receptor-β. Progesterone receptor deficiency causes progesterone resistance. Populations of endometrial and endometriotic epithelial cells also harbor multiple cancer driver mutations, such as KRAS, which may be associated with the establishment of pelvic endometriosis or ovarian cancer. It is not known how interactions between epigenomically defective stromal cells and the mutated genes in epithelial cells contribute to the pathogenesis of endometriosis. Endometriosis-associated pelvic pain is managed by suppression of ovulatory menses and estrogen production, cyclooxygenase inhibitors, and surgical removal of pelvic lesions, and in vitro fertilization is frequently used to overcome infertility. Although novel targeted treatments are becoming available, as endometriosis pathophysiology is better understood, preventive approaches such as long-term ovulation suppression may play a critical role in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since P4 signaling is required to counteract E2-induced proliferation and to promote decidualization [55], the loss of P4-responsiveness leads to both an increased growth of endometriotic lesions and to a non-receptive endometrium [33, 56].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During the follicular phase, estrogen acts on eutopic endometrium through the estrogen receptor (ER) to increase transcription and protein levels of the progesterone receptor (PR), especially the PR-B isoform.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in endometriotic implants, ERα is reduced but ERβ activity is upregulated, leading to complete loss of PR-B, which is then unable to induce 17β-HSD2.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Clear data show that endometriotic tissue expresses the entire set of steroidogenic genes, including aromatase, allowing to local de-novo estradiol (E2) production. [33]”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“PR resistance in endometriotic cells results in CRABP2 deficiency, thereby favoring survival, development and persistence of endometriotic implants [15,16].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [15]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Sampson, J. A. (1927) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30003-x · Cited by 2,334
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Giudice, L. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1000274 · Cited by 1,924
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Self-citationARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Eskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
(1927) · PubMed Central · Cited by 1,008
Immunobiology of endometriosis
Lebovic, D. I., Mueller, M. D., & Taylor, R. N. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01630-7 · Cited by 857
Research works printed but not linked: 3
- Evers J, Dunselman G, Land J, Bouckaert P, Van Der Linden P. Management of recurrent endometriosis. In: Coutinho EM, Spinola P, Hanson de Moura L, eds. Progress in the Management of Endometriosis. London, UK: Parthenon Publishing Group; 1995:291–297. [Google Scholar]
- Bulun SE. Endometriosis. In: Strauss J, Barbieri R, eds. Yen & Jaffe’s Reproductive Endocrinology. 8th ed. Philadelphia, PA: Elsevier; 2019:609–642. [Google Scholar]
- Bulun S, Adashi E. The physiology and pathology of the female reproductive axis. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology, 10th ed. Philadelphia, PA: Elsevier Health Sciences; 2003:587–663. [Google Scholar]
Cited by
Items 501–600 of 944
Magnetic Resonance Roadmap in Detecting and Staging Endometriosis: Usual and Unusual Localizations
Piccolo, C. L., Cea, L., Sbarra, M., Nicola, A. M. D., Nardone, C. D. C., Faiella, E., Grasso, R. F., & Zobel, B. B. (2023) · Applied Sciences · doi:10.3390/app131810509 · Cited by 4
Evaluación de la calidad de vida en pacientes con endometriosis mediante una escala original
Hernández, D. M. O., Valencia, L. E. G., & Gómez, G. G. (2023) · Acta Médica Grupo Ángeles · doi:10.35366/112645 · Cited by 5
Pirš, B., Vengušt, E., & Vrtačnik, E. B. (2024) · Human Fertility · doi:10.1080/14647273.2024.2309389 · Cited by 5
“…condition is one of the main causes of chronic pelvic pain in women, as well as dysmenorrhoea, dyspareunia infertility, constipation and/or diarrhoea, painful defaecation and/or urination, heavy menstrual bleeding, fatigue and depression and infertility (Bulun et al., 2019; Saunders & Horne, 2021).”
HIF-1α regulates DcR3 to promote the development of endometriosis
Guan, J., Huang, X., Zhou, Z., Li, S., Wang, F., Han, Y., & Yin, N. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.02.035 · Cited by 4
Lin, T.-C., Wang, K., Chuang, K., Kao, A., & Kuo, T. (2024) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2024.01.012 · Cited by 4
Erturun, A. G., Dilbaz, B., Aksan, A., & Üstün, Y. E. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.06.020 · Cited by 4
FOXL2 Knockdown Inhibits the Progression of Endometriosis
Zhang, B., Li, S., Yuan, H., Cong, S., Zhao, S., & Yang, X. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70043 · Cited by 4
Future of Sclerotherapy in the Treatment of Endometriosis: A Narrative Literature Review.
Lentzaris, D., Gkrozou, F., Skentou, C., Koutalia, N., Bais, V., Vatopoulou, A., & Paschopoulos, M. E. (2025) · PubMed Central · doi:10.7759/cureus.81215 · Cited by 6
Gosset, A., Escanes, C., Pouillès, J. M., Vidal, F., Gac, Y. T. L., Plu‐Bureau, G., & Trémollières, F. (2020) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001696 · Cited by 4
Münch, F., Ebert, A. D., Mechsner, S., Richter, R., & David, M. (2022) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/22840265211073017 · Cited by 4
Idrissi, F. E., Fruchart, M., Bélarbi, K., Lamer, A., Dubois‐Deruy, E., Lemdani, M., N’Guessan, A., Guinhouya, B. C., & Zitouni, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.869053 · Cited by 4
“Endometriosis is de fi ned by implantation and invasive growth of endometrial tissue in extra-uterine locations, causing chronic pelvic pain, dyspareunia, dysmenorrhea, menorrhagia, bowel symptoms, and infertility (1, 6, 8).”
BackgroundInfluentialSignorile, P. G., Baldi, A., Viceconte, R., Vincenzi, B., & Montella, M. (2023) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2023047178 · Cited by 4
Paik, H., Jeong, H. G., & Jee, B. C. (2023) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2023.07.008 · Cited by 4
Daoud, E., Archer, D. F., Parazzini, F., & Herranz‐Blanco, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147667 · Cited by 5
“It is characterized by the presence of endometrial-like tissue outside the uterus, commonly affecting the pelvic cavity, ovaries, fallopian tubes, and other surrounding structures [2].”
BackgroundScioscia, M., Roman, H., Somigliana, E., & Robillard, P. (2019) · Human Reproduction · doi:10.1093/humrep/dez192 · Cited by 4
Endometriosis - Pathogenesis, diagnosis and treatment
Kwiatkowski, P., Gładysz, K., Szydłowska, J., ŻUCHNIK, O., KRÓL, O., Kuczyńska, B., Czelej, M., KŁOS, A., GIEROBA, K., & Szydłowski, M. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.13.03.039 · Cited by 5
Endocrine Disruption in Women: A Cause of PCOS, Early Puberty, or Endometriosis
Wenger, J. M., & Marci, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-36494-5_5 · Cited by 3
Karataş, E., Temiz, B. E., Mümüşoğlu, S., Yaralí, H., & Bozdağ, G. (2024) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.galenos.2024.2022-9-4 · Cited by 3
“with infertility and hence approximately 40% of infertile women with endometriosis are reported to have visible OMA cysts (7).”
Proestling, K., Schreiber, M. J., Miedl, H., Hudson, Q. J., Husslein, H., Kuessel, L., Gstoettner, M., Wenzl, R. J., & Yotova, I. (2024) · Biomedicines · doi:10.3390/biomedicines12081657 · Cited by 5
“This leads to increased estrogen-induced cell proliferation and inflammation, which, together with concurrent progesterone resistance, can promote both the development of ectopic endometriosis lesions [9,10] and reduced endometrial receptivity of women with the disease [8,11,12].”
BackgroundYu-Wen, S., Zheng, Q., Liao, C., Wei, L., Yang, S., & Li, N. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110393 · Cited by 2
Adamczyk, M., Rawłuszko-Wieczorek, A. A., Wirstlein, P. K., Nowacka, M., Nowicki, M. O., Jagodziński, P. P., Wender-Ożegowska, E., & Kędzia, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-13618-8 · Cited by 3
Kusama, K., Ashihara, M., Okita, M., Yoshida, K., Suzuki, M., Suzuki, K., Hosokawa, R., Yoshie, M., Kojima, J., Mizuno, Y., et al. (2025) · Molecular Reproduction and Development · doi:10.1002/mrd.70046 · Cited by 4
“and epithelial cells travel backward through the fallopian tubes into the pelvic cavity (Bulun et al. 2019; Giudice and Kao 2004).”
Yang, Q., Hong, J., Zheng, X., Liu, X., Lin, H., Chen, L., Zhong, F., Zhang, Q., Jiang, J., & Sun, P. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s537221 · Cited by 3
Pain pathways and stem cells in endometriosis pathogenesis
Aydin, H., & Elbe, H. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10973-7 · Cited by 3
Liu, X., An, R., & Wang, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-26606-9 · Cited by 5
Elbanna, A. H., El‐Dessouki, A. M., Mageed, S. S. A., Ghaiad, H. R., Khalaf, S. S., Gad, E. S., Abdou, K., Aborehab, N. M., El‐Shiekh, R. A., & Hamdy, S. A. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04797-2 · Cited by 6
Role of Phytoestrogens in Endometriosis
Sulak, M. M., & Halıcı, Z. (2025) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.70158 · Cited by 3
Mao, X., Yang, X., Zhu, Y.-N., Sun, M.-M., Ye, F., San, S.-G., Tang, J., Shen, L., Xing, H., & Meng, K. (2026) · European journal of medical research · doi:10.1186/s40001-026-03855-6 · Cited by 3
The Hidden Link Between Endometriosis and Obesity: A State-of-the-Art Review
Desai, S., Reed, C. C., Mendez, Y. H., Yang, Q., & Guan, X. (2026) · Cureus · doi:10.7759/cureus.102896 · Cited by 4
Zhu, J., Wu, P., Ma, Y., Peng, Z., Fa, H., Qin, L., Geng, M., Lu, R., Zeng, C., Wu, N., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69551-5 · Cited by 2
“While retrograde menstruation of endometrial tissue is routinely observed in almost all ovulatory women, only 10% of these women develop endometriosis 6 , suggesting that the ability of endometrial tissue to implant outside the uterus is crucial for the occurrence of endometriosis.”
Güzelbağ, B., Güngör‐Ordueri, N. E., Karahan, H., Maghsoudi, A., & Oral, E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073034 · Cited by 3
“Iron released during retrograde menstruation leads to excessive production of reactive oxygen species through the Fenton reaction, causing DNA damage [7,8].”
Donnez, J., Becker, C. M., Petraglia, F., Horne, A. W., Becker, S., Renner, S. P., Herrera, F. C., Taylor, H. S., Paszkowski, M., Bestel, E., et al. (2026) · Human Reproduction Open · doi:10.1093/hropen/hoag030 · Cited by 3
Nemeti, G. I., Craciun, A. E., Măgureanu, D. C., Militaru, F. C., Bocșan, I. C., Crăciun, C.-I., Rusu, A., Melincovici, C. S., Buzoianu, A. D., Mureșan, D., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114883 · Cited by 4
“Lesion persistence and recurrence are additionally supported by endometrial mesenchymal stem/stromal cells (eMSCs), which display enhanced migratory and adhesive behaviors and contribute directly to fibrotic remodeling [20,67–70].”
THEORETICAL AND APPLIED ASPECTS OF THE DEVELOPMENT OF SCIENCE
International Science Group, & Vladlenov, D. (2023) · doi:10.46299/isg.p.2023.1.18 · Cited by 3
Ishikawa, H., Yoshino, O., Taniguchi, F., Harada, T., Momoeda, M., Osuga, Y., Hikake, T., Hattori, Y., Hanawa, M., Inaba, Y., et al. (2024) · Reproductive Health · doi:10.1186/s12978-024-01739-8 · Cited by 3
Spain, J., Powell, Z., & Davis, C. (2024) · Australian Social Work · doi:10.1080/0312407x.2024.2362140 · Cited by 3
Wang, J., Liang, Y., Liang, X., Peng, H., Wang, Y., Xu, M., Liang, X., Yao, H., Liu, X., Zeng, L., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1426660 · Cited by 6
“Currently, the treatment for EMS relies on surgical removal and hormone suppression (Bulun et al., 2019), which includes Gonadotropin-releasing hormone (GnRH) antagonists and progestins.”
BackgroundSignorile, P. G., Baldi, A., Viceconte, R., Carraturo, E., Boccellino, M., Fordellone, M., & Montella, M. (2024) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2024054273 · Cited by 3
Wu, C., Li, C., Fang, Y.-Y., Wu, H., Ji, D.-M., Zhou, P., Cao, Y., He, Y., & Wei, Z. (2024) · World Journal of Psychiatry · doi:10.5498/wjp.v14.i9.1364 · Cited by 3
Endometriosis – hormones and treatment
Obrycka, P., Soczyńska, J., Gawełczyk, W., Tomecka, P., & Mozdziak, P. E. (2024) · Medical Journal of Cell Biology · doi:10.2478/acb-2024-0008 · Cited by 3
Huang, X., Xu, R., Yang, Q. Z., Jiang, X., Lin, J.-J., Zhao, H., Wu, R., Du, H., & Dai, W. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1505958 · Cited by 3
Evaluation of the Epidemiological Disease Burden and Nationwide Cost of Endometriosis in Hungary
Pónusz-Kovács, D., Pónusz, R., Kajos, L., Csákvári, T., Kovács, B., Várnagy, Á., Kovács, K. A., Bódis, J., & Boncz, I. (2024) · Healthcare · doi:10.3390/healthcare12242567 · Cited by 3
Barinov, S. V., Лазарева, О. В., Tirskaya, Y. I., Кадцына, Т. В., Tshulovsky, Y. I., Khoroshkin, Y. A., Shkabarnya, L. L., Ellert, A. N., & Сидорина, И. И. (2025) · Ural Medical Journal · doi:10.52420/umj.24.1.26 · Cited by 3
Hassanein, H. H., WalyEldeen, A. A., Sayed, R. M. S., Taha, A., Ibrahim, S., & Hassan, H. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.102867 · Cited by 3
Yazıcıoğlu, Ç., Yücetürk, A., Karaosmanoğlu, Ö., Aslan, İ. Ö., Peker, N., Çakıroğlu, Y., & Tıraş, B. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07492-5 · Cited by 3
Lin, H., Zheng, L., He, Y.-F., Fang, Y., Chen, H., Chen, K., & Zhou, S.-G. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11151-x · Cited by 3
“Endometriosis (EM), one of the most prevalent disorders affecting females, is characterized by the aberrant proliferation of endometrial tissues outside the uterus, primarily involving ovaries and pelvic cavity (Bulun et al. 2019).”
Park, Y., Sung, N., Kim, E., Jeong, J., Sim, J., Park, M. J., Lydon, J. P., Guan, X., & Han, S. J. (2025) · Endocrinology · doi:10.1210/endocr/bqaf146 · Cited by 3
Koninckx, P. R., Ussia, A., Adamyan, L. V., Wattiez, A., & Viganò, P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207196 · Cited by 3
“Individual lesions vary biochemically, with variable aromatase activity and progesterone resistance [17,18].”
Артымук, Н. В., Chervov, V. O., Данилова, Л. Н., Поленок, Е. Г., & Zotova, O. A. (2021) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2020-0056 · Cited by 3
Darbà, J., & Marsà, A. (2021) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1936502 · Cited by 4
Peng, J., Wang, R. L., Ding, Z., & Song, X. (2021) · Medicine · doi:10.1097/md.0000000000026699 · Cited by 5
Oliveira, F. R., Casalechi, M., Carneiro, M. M., de Ávila, I., Cruz, C. D., Puerto, H. L. D., Camargos, A. F., Abrão, M. S., & dos Reis, F. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06685-3 · Cited by 3
Епідеміологія синдрому полікістозних яєчників, ендометріозу та їх коморбідного перебігу
Досвальд, А. С. Х., Khmil, M. S., & Хміль, С. В. (2022) · Bulletin Of Medical And Biological Research · doi:10.11603/bmbr.2706-6290.2021.4.12662 · Cited by 3
Histomorphometric analysis of the endometrium in an ectopic model of endometriosis in mice
da Silva, F. R., Thimoteo, D. S., Carbonel, A. A. F., Fuchs, L. F. P., Sasso, G. R. D. S., Simões, R. S., Invitti, A. L., Vieira, R. R., Ferreira, L. P. D. S., da Silva, R. A., et al. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2119218 · Cited by 3
Ruiz-Magaña, M. J., Puerta, J. M., Llorca, T., Méndez-Malagón, C., Martínez-Aguilar, R., Abadía‐Molina, A. C., Olivares, E. G., & Ruiz‐Ruiz, C. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.12.005 · Cited by 3
Dinsdale, N. L., Chizen, D. R., & Crespi, B. J. (2023) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/22840265231178334 · Cited by 4
Adamyan, L. V., Николаевич, Ш. М., Murvatov, K. D., Kiselev, S. I., Arslanyan, K. N., Chernetsova, A. S., & Prokofieva, Y. S. (2023) · Russian Journal of Human Reproduction · doi:10.17116/repro20232903191 · Cited by 4
Immunologic Aspects of Endometriosis
Young, A. N., Maghsoudlou, P., King, L. P., Rogers, M. S., & Hornstein, M. D. (2024) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-024-00373-2 · Cited by 3
“Endometriotic lesions upregulate enzymes that can increase local availability of estrogen, including aromatase, which coverts androgens to estrogens, and steroidogenic acute regulatory protein (StAR), which recruits intracellular cholesterol for steroid hormone production [1].”
InfluentialWei, L., Wang, S., Xu, S., & Zhang, C. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104293 · Cited by 3
The impact of endometriosis on women's mental health and quality of life – review
Nowocin, P., Kudas, Z., Koszyk, M., Litwin, A., Krzywicka, K., Kulczyński, D. W., Dąbrowska, N., Kumięga, P., Perchel, N., & Wasiński, P. (2024) · Medical Science · doi:10.54905/disssi.v28i154.e160ms3483 · Cited by 3
Shero, N., & Kim, D. S. (2022) · Case Reports in Women s Health · doi:10.1016/j.crwh.2022.e00466 · Cited by 3
Baugh, L. M., Goods, B. A., Gnecco, J. S., Bae, Y., Retchin, M. R., Tzouanas, C. N., Loring, M., Isaacson, K., Shalek, A. K., Lauffenburger, D. A., et al. (2022) · medRxiv · doi:10.1101/2022.01.29.22269829 · Cited by 3
Uncovering the Cellular and Molecular Landscape of Gynecological Disorders
Yang, Q. (2025) · Cells · doi:10.3390/cells14171399 · Cited by 3
“The role of hormonal dysregulation, particularly estrogen, is well established in the initiation, progression, and persistence of the disease [23].”
Gogusev, J., Lepelletier, Y., Cohen, H., Ami, O., & Validire, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020775 · Cited by 2
“Other pathogenetic concepts emphasize the activation of a local inflammatory process due to growth factor anomalies [14,15], estrogen stimulation through estrogen-binding receptors [16] and potential epigenetic changes [17].”
Gupta, S. C., Tripathi, R., Kawale, A. K., Sarkar, S., Singh, A., Verma, R. K., Sankhwar, P., Sharma, V., & Jha, R. K. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151509 · Cited by 2
Barik, M., & Duddi, S. R. (2025) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2544 · Cited by 3
Systemic comorbidities in patients with adenomyosis
Gallone, A., Vannuccini, S., Manzi, V., Torre, F. L., Toscano, F., Giani, M., Fambrini, M., Chedraui, P. A., & Petraglia, F. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.105102 · Cited by 4
Howe, C. A., Coté, J. J., Stoos, C., Bredehoeft, M., Hallgren, J., & Waes, J. B. G. (2025) · Journal of the American Association for Laboratory Animal Science · doi:10.30802/aalas-jaalas-24-160 · Cited by 2
Mechanisms of KLF10 in Regulating Proliferation of Endometriotic Stromal Cells in Endometriosis
Xia, B., Liu, Y., Li, J., & Jiang, S. (2025) · Gynecologic and Obstetric Investigation · doi:10.1159/000546836 · Cited by 2
Atsama, P. M., Djiogue, S., Awounfack, C. F., & Njamen, D. (2025) · Reproduction and Fertility · doi:10.1530/raf-24-0084 · Cited by 3
Wei, C., Liu, Y., Chen, S., Li, M., Li, D., Zhu, X., & Zhang, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146627 · Cited by 2
miRNA expression haplotype in Hispanics with endometriosis
Alday-Montañez, F. D., Lariz-Nevárez, B. D., Carrasco-Urrutia, V. J., Dickens-Terrazas, D., Barragán-Farías, A., Mejía-Carmona, G. E., Kirken, R. A., Bencomo-Alvarez, A. E., Lobo-Galo, N., Vargas-Caraveo, A., et al. (2025) · Frontiers in Reproductive Health · doi:10.3389/frph.2025.1663755 · Cited by 2
Pain, Emotions, Interoception, and Bodily Sensations in Patients With Endometriosis
Pasternack, S., Suvilehto, J. T., Härkki, P., Heikinheimo, O., Sipilä, R. M., & Kalso, E. A. (2025) · European Journal of Pain · doi:10.1002/ejp.70144 · Cited by 2
Zhou, X., Zhou, W. J., Qu, C., Jiang, Y., Liu, W., & Pei, L. (2025) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00262 · Cited by 2
You, Y., Luo, Y., & Li, P. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s535948 · Cited by 2
Kikuno, K., Asada, R., Ishihara, T., Morishige, K.-I., Chikazawa, K., Furui, T., & Isobe, M. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03397-z · Cited by 2
“Endometriosis is a chronic, estrogen‑dependent gynecological disorder that impairs women’s qual‑ ity of life and often requires long‑term hormonal treatment to prevent recurrence [1–5].”
Liu, X., An, R., Zhang, P., Yang, Q., Wang, S., Jiao, X., Xu, L., Ren, Q., & Wang, G. (2026) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03781-2 · Cited by 2
Wang, L., & Xing, Y. (2026) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-026-08355-w · Cited by 2
“Recent studies have revealed that EMS lesions and peritoneal fluid in affected patients contain a high concentration of inflammatory cells, cytokines, and chemokines, creating a distinct inflammatory microenvironment [16, 19].”
Integrating Metabolic and MicroRNA Profiling to the Diagnostics of Endometriosis: A Pilot Study
Shansky, Y. D., Esiev, S. S., Pokazannikova, U. V., Kudryavtseva, Y. V., Chursina, L., & Bespyatykh, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073052 · Cited by 2
“The transvaginal ultrasound examination is widely used to diagnose endometriosis being much less invasive compared to laparoscopy [49,50], but it generally exhibits lower sensitivity and heavily depends on the expertise of the examining physician [48].”
Lee, J. H., Jung, G. S., Kim, K., Park, H., Park, Y., Lee, I., Lee, M. J., Lee, J.-H., Choi, Y. S., & Cho, S. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03689-25 · Cited by 2
“endometriosis affects only approximately 10% of women, whereas retrograde menstru ation of EM tissue mixed with blood is routinely observed in nearly all ovulatory women (4), it is improbable that this phenomenon is the sole cause of the disease.”
Hormonal Dysregulation and Neuroinflammation in Endometriosis: Convergent Druggable Pathways
Olteanu, I.-L., Pușcașu, C., Andrei, C., & Zanfirescu, A. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48050528 · Cited by 3
Wang, N., Liu, B., Zhang, Y., Man, X.-H., Jiang, R., Yao, L., Dong, X., Guo, M., Sun, J., & Bi, J. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117079 · Cited by 2
Natural Products Targeting Oxidative Stress–Inflammation Crosstalk in Endometriosis
Mhatre, D., Jadhav, T., Shirodkar, S., & Doshi, G. (2026) · American Journal of Reproductive Immunology · doi:10.1111/aji.70293 · Cited by 2
Tomita, S., Mehrotra, M., Chaoul, J., Houldsworth, J., Kolev, V., & Kalir, T. (2021) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2021.100718 · Cited by 2
Yarmolinskaya, M. I., Durneva, E. I., Chepanov, S. V., Соколов, Д. И., & Selkov, S. А. (2021) · Russian Journal of Human Reproduction · doi:10.17116/repro20212702141 · Cited by 2
ENDOMETRIC FACTOR OF ENDOMETRIOSIS-ASSOCIATED INFERTILITY
Orazov, M. R., Radzinsky, V. E., Khamoshina, M. B., Владимировна, В. С., Abitova, M. Z., & Shustova, V. B. (2020) · Репродуктивная медицина · doi:10.37800/rm2020-1-22 · Cited by 2
Examining Diagnostic Options and Classification Systems Available for Endometriosis
Ghosh, D., & Sengupta, J. (2021) · EMJ Reproductive Health · doi:10.33590/emjreprohealth/21-00015 · Cited by 2
Estudo epidemiológico da endometriose no Estado do Maranhão
Santos, K. F. A., Cunha, E. R., Mendes, L. E. B., Ribeiro, A. A., Araújo, S. R. M., Pereira, T. V., Pereira, E. F. C., Pereira, S. J., Fróes, J. M. L., & de Souza, M. T. P. (2022) · Research Society and Development · doi:10.33448/rsd-v11i15.37163 · Cited by 2
Gürgan, T., & Bektaş, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89907-9.00014-4 · Cited by 2
Endometriosis. Is spontaneous pregnancy possible with ovarian endometriosis?
СЛОБОДЯНИК, О. Я., Demyanenko, A. S., Kostenko, O. Y., Poladych, I. V., & Гужевська, І. В. (2022) · Reproductive health of woman · doi:10.30841/2708-8731.6.2022.267682 · Cited by 2
Zhang, Y., Wu, L., Wen, X., & Lv, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18277 · Cited by 2
Andreeva, N. Y., Yarmolinskaya, M. I., Владимировна, М. Е., & Tkachenko, N. N. (2023) · Journal of obstetrics and women s diseases · doi:10.17816/jowd567975 · Cited by 2
Genetic alteration of mRNA editing enzyme APOBEC3B in the pathogenesis of ovarian endometriosis
Balasubramanian, V., Saravanan, R., Srikanth Swamy Swaroop, B., Rajendran, S., Joseph, L. D., Dev, B., Srinivasan, B., Balunathan, N., Shanmugasundaram, G., Gopisetty, G., et al. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104111 · Cited by 3
Vannuccini, S., Aslan, B., & Petraglia, F. (2024) · ISGE series · doi:10.1007/978-3-031-55300-4_9 · Cited by 2
Zhang, X., Wang, X., Li, R., Zhang, C., Du, J., Zhao, H., & Wen, Q. (2024) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01402-2 · Cited by 2
“Endometriosis is a common gynecological and obstetric disease characterized by the presence of nodules and masses that can cause pain and infertility [1, 2].”
Dysmenorrhea and endometriosis in the adolescent female
Davis‐Kankanamge, C., & Vash‐Margita, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10512-8.00019-9 · Cited by 4
Li, Y., Li, Y., Lu, Y., Lin, Y., Wang, X., Zhu, Y. Z., Zeng, Q., & Du, M. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024178 · Cited by 2
Jia, Q., Tang, H., Zhong, X., Chen, W., Wu, Y., Wei, W., Zheng, H. Y., & Chen, J. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01531-z · Cited by 2
Qin, Y., Yang, X., Zhao, Q., Tang, X., Zhao, H., Jiao, Y., & Zhou, H. (2024) · Medicine · doi:10.1097/md.0000000000040528 · Cited by 3
Metadata
- Authors
- Bulun, S. E., Yilmaz, B. D., Sison, C., Miyazaki, K., Bernardi, L., Liu, S., Kohlmeier, A., Yin, P., Milad, M., & Wei, J.
- Affiliations
- Northwestern University (US)
- Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
- Corresponding author
- Bulun, Serdar E
- ORCID
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-04-17
- Volume
- 40
- Issue
- 4
- Pages
- 1048-1079
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC6693056
- OpenAlex
- W4211072069
- Semantic Scholar
- 65040787dce0d5e2c5ea1422c1499c9646f18963
- Cited by
- 844
- References
- 214
- Citations by year
- 2026: 105 · 2025: 163 · 2024: 158 · 2023: 134 · 2022: 121 · 2021: 91 · 2020: 64 · 2019: 8
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Child Health and Human Development (HD38691)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- pelvic endometriosis, chronic pelvic pain, infertility, endometrial mesenchymal stem cells, epigenetic abnormalities, GATA6, steroidogenic factor 1, estrogen receptor beta, progesterone resistance, KRAS mutation, ovarian cancer, ovulation inhibition, cyclooxygenase inhibitors, in vitro fertilization, targeted therapy
- MeSH terms
- Animals, Endometriosis, Endometrium, Female, Humans, Receptors, Progesterone, Uterine Diseases, Stromal Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.